Researchers identified two distinct epigenetic states that emerge during early development, each associated with varying ...

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

The Prevent Cancer Foundation® is pleased to announce new funding for ten scientists who are exploring innovative approaches ...

A groundbreaking study has identified two distinct epigenetic states formed during early development that determine cancer ...

For patients undergoing prostate radiotherapy, acute toxicity is associated with late toxicity and decrement in qua ...

Robotic bronchoscopy can help diagnose spots in the lungs when they are still small, catching cancer sooner and saving many ...

KYZATREX is a controlled substance (CIII) because it contains testosterone. It is not known if KYZATREX is safe or effective in males younger than 18 years old. Improper use may affect bone growth in ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...

"The scale and scope of data to be presented at the ASCO GU meeting underscore the impact our whole-transcriptome-based Decipher tests are having in treating patients with urologic cancers, and how ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...